View in EDS HTML Full Text PDF Full Text

Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.

Saved in:
Bibliographic Details
Title: Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.
Authors: Baker, Joshua F.1 (AUTHOR), Bakewell, Catherine2 (AUTHOR), Dikranian, Ara3 (AUTHOR), Lam, Gordon4,5 (AUTHOR), O'Brien, Jacqueline6 (AUTHOR), Moore, Page C.6 (AUTHOR), Yu, Miao6 (AUTHOR), Hur, Peter7 (AUTHOR), Masri, Karim R.8 (AUTHOR) karim.masri@pfizer.com
Source: Rheumatology & Therapy. Jun2024, Vol. 11 Issue 3, p841-853. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-024-00653-6